ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.

Suppr

超能文献

作者信息

Bakowski M T

出版信息

Cancer Treat Rev. 1976 Jun;3(2):95-107. doi: 10.1016/s0305-7372(76)80007-2.

DOI:10.1016/s0305-7372(76)80007-2

PMID:821609

Abstract

摘要

相似文献

ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.

Cancer Treat Rev. 1976 Jun;3(2):95-107. doi: 10.1016/s0305-7372(76)80007-2.

The effect of (+/-) 1,2-bis(3,5-dioxopiperazin-1-yl) propane (ICRF 159) on liver metastases from a hamster lymphoma.

Eur J Cancer (1965). 1975 Jun;11(6):383-8. doi: 10.1016/0014-2964(75)90068-7.

A study of antitumor (phase II) and immunosuppressive effects of ICRF-159 in patients with metastatic melanoma.

J Clin Pharmacol. 1976 Aug-Sep;16(8-9):433-8. doi: 10.1002/j.1552-4604.1976.tb02418.x.

Clinical trials with bis-dioxopiperazine propane (ICRF 159; NSC 129, 943) in acute leukaemias.

Osterr Z Onkol. 1975;2(4):112-4.

Radiotherapy combined with ICRF 159 (NSC 129943).

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):121-6. doi: 10.1016/0360-3016(78)90126-8.

ICRF-187 in clinical oncology.

Cancer Clin Trials. 1981;4(2):143-6.

Antimetastatic effects of razoxane in a rat osteosarcoma model.

Clin Exp Metastasis. 1987 Jan-Mar;5(1):9-16. doi: 10.1007/BF00116621.

Prenatal effects of the cancer chemotherapeutic drug ICRF 159 in mice, rats, and rabbits.

Teratology. 1975 Feb;11(1):119-26. doi: 10.1002/tera.1420110114.

Inhibition of the R3327MAT-Lu prostatic tumor by diethylstilbestrol and 1,2-bis(3,5-dioxopiperazin-1-yl)propane.

Cancer Res. 1982 Apr;42(4):1390-4.

Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer.

Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):115-9. doi: 10.1016/0360-3016(78)90125-6.

引用本文的文献

The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane.

Sarcoma. 2006;2006(1):87367. doi: 10.1155/SRCM/2006/87367.

Combined razoxane and radiotherapy for melanoma brain metastases. a retrospective analysis.

J Neurooncol. 2005 Sep;74(3):295-9. doi: 10.1007/s11060-004-7557-z.

Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane.

Br J Cancer. 2003 Jul 21;89(2):262-7. doi: 10.1038/sj.bjc.6601105.

Metal binding by pharmaceuticals. Part 2. Interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192.

Agents Actions. 1982 Oct;12(4):536-42. doi: 10.1007/BF01965940.

Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.

Cancer Chemother Pharmacol. 1982;8(3):293-9. doi: 10.1007/BF00254053.

Lead elimination of ICRF 158 in rats after chronic lead exposure.

Int Arch Occup Environ Health. 1981;48(1):89-98. doi: 10.1007/BF00405935.

The cytokinetic and cytotoxic effects of ICRF-159 and ICRF-187 in vitro and ICRF-187 in human bone marrow in vivo.

Invest New Drugs. 1983;1(4):283-95. doi: 10.1007/BF00177411.

Anticancer chemotherapy.

Br Med J (Clin Res Ed). 1983 Jul 9;287(6385):110-3. doi: 10.1136/bmj.287.6385.110.

Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.

Clin Exp Metastasis. 1984 Oct-Dec;2(4):321-31. doi: 10.1007/BF00135171.

The mutagenic activity of razoxane (ICRF 159): an anticancer agent.

Br J Cancer. 1985 Nov;52(5):725-31. doi: 10.1038/bjc.1985.250.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验